Company profile for Castle Creek Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Castle Creek Pharma is a fully integrated pharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs. We have rapidly assembled a robust and diversified late stage pipeline of innovative and high potential products in orphan dermatology. We pride ourselves on the strong relationships that we have forged with our key partners in industry, academia and patient based organizations, which have been inst...
Castle Creek Pharma is a fully integrated pharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs. We have rapidly assembled a robust and diversified late stage pipeline of innovative and high potential products in orphan dermatology. We pride ourselves on the strong relationships that we have forged with our key partners in industry, academia and patient based organizations, which have been instrumental in helping us to advance our products rapidly in development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6 Century Drive, 2nd Floor Parsippany, New Jersey, 07054
Telephone
Telephone
(862) 286-0400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/castle-creek-biosciences-announces-publication-of-preclinical-study-for-potential-in-vivo-gene-therapy-in-nature-communications-301614779.html

PRNEWSWIRE
30 Aug 2022

https://endpts.com/scoop-after-pulling-ipo-ambitions-last-december-jeff-aronins-castle-creek-turns-to-private-backers/

Kyle LaHucik ENDPTS
20 May 2022

https://endpts.com/a-jeff-aronin-startup-quietly-yanks-its-ipo-as-the-biotech-market-ends-year-on-a-whimper/

John Carroll ENDPTS
30 Dec 2021

https://www.prnewswire.com/news-releases/castle-creek-biosciences-awarded-fda-orphan-products-development-grant-to-support-defi-rdeb-a-pivotal-phase-3-study-of-fcx-007-investigational-gene-therapy-for-recessive-dystrophic-epidermolysis-bullosa-301405636.html

PRNEWSWIRE
21 Oct 2021
3-peat Friday: Castle Creek, Eliem and Adagio file for IPOs
3-peat Friday: Castle Creek, Eliem and Adagio file for IPOs

19 Jul 2021

// Kyle LaHucik FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/castle-creek-eliem-and-adagio-three-biotechs-filed-for-ipos-friday-continued-public-frenzy

Kyle LaHucik FIERCEBIOTECH
19 Jul 2021

https://www.prnewswire.com/news-releases/castle-creek-biosciences-announces-first-patient-dosed-in-defi-rdeb-phase-3-clinical-trial-of-debcoemagene-autoficel-d-fi-gene-therapy-for-recessive-dystrophic-epidermolysis-bullosa-301161536.html

PRNEWSWIRE
28 Oct 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty